Senescence marker protein 30 has a cardio-protective role in doxorubicin-induced cardiac dysfunction

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Miyata, Makiko ^a   Suzuki, Satoshi ^a   Misaka, Tomofumi ^a   Shishido, Tetsuro ^b   Saitoh, Shu Ichi ^a   Ishigami, Akihito ^c   Kubota, Isao ^b   Takeishi, Yasuchika ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ANIMALS; APOPTOSIS; ASCORBIC ACID; BCL-2-ASSOCIATED X PROTEIN; BIOLOGICAL MARKERS; CALCIUM-BINDING PROTEINS; CARDIOTONIC AGENTS; CASPASE 3; DNA DAMAGE; DOXORUBICIN; FIBROSIS; HEART FAILURE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MYOCARDIUM; MYOCYTES, CARDIAC; OXIDATIVE STRESS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; STROKE VOLUME; UP-REGULATION;

EID: 84894282972     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079093     Document Type: Article

References (36)

1. Pai VB, Nahata MC (2000) Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention. Drug Saf 22: 263-302. (Pubitemid 30213944)
2. Smith LA, Cornelius VR, Plummer CJ, Levitt G, Verrill M, et al. (2010) Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials. BMC Cancer 10: 337.
3. Von Hoff DD, Layard MW, Basa P, Davis HL Jr, Von Hoff AL, et al. (1979) Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 91: 710-717. (Pubitemid 10218041)
4. Takemura G, Fujiwara H (2007) Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management. Prog Cardiovasc Dis 49: 330-352. (Pubitemid 46295436)
5. Neilan TG, Blake SL, Ichinose F, Raher MJ, Buys ES, et al. (2007) Disruption of nitric oxide synthase 3 protects against the cardiac injury, dysfunction, and mortality inducedby doxorubicin. Circulation 116: 506-514. (Pubitemid 47450259)
6. Menna P, Minotti G, Salvatorelli E (2007) In vitro modeling of the structure-activity determinants of anthracycline cardiotoxicity. Cell Biol Toxicol 23: 49-62. (Pubitemid 44950188)
7. Wang M, Zhang J, Walker SJ, Dworakowski R, Lakatta EG, et al. (2010) Involvement of NADPH oxidase in age-associated cardiac remodeling. J Mol Cell Cardiol 48: 765-772.
8. Fujita T, Uchida K, Maruyama N (1992) Purification of senescence marker protein-30 (SMP30) and its androgen-independent decrease with age in the rat liver. Biochim Biophys Acta 1116: 122-128.
9. Fujita T, Mandel JL, Shirasawa T, Hino O, Shirai T, et al. (1995) Isolation of cDNA clone encoding human homologue of senescence marker protein-30 (SMP30) and its location on the X chromosome. Biochim Biophys Acta 1263: 249-252.
10. Fujita T, Inoue H, Kitamura T, Sato N, Shimosawa T, et al. (1998) Senescence marker protein-30 (SMP30) rescues cell death by enhancing plasma membrane Ca(2+)-pumping activity in Hep G2 cells. Biochem Biophys Res Commun 250: 374-380. (Pubitemid 28463885)
11. Son TG, Kim SJ, Kim K, Kim MS, Chung HY, et al. (2008) Cytoprotective roles of senescence marker protein 30 against intracellular calcium elevation and oxidative stress. Arch Pharm Res 31: 872-877.
12. Kondo Y, Inai Y, Sato Y, Handa S, Kubo S, et al. (2006) Senescence marker protein 30 functions as gluconolactonase in L-ascorbic acid biosynthesis, and its knockout mice are prone to scurvy. Proc Natl Acad Sci U S A 103: 5723-5728.
13. Ishigami A, Fujita T, Handa S, Shirasawa T, Koseki H, et al. (2002) Senescence marker protein-30 knockout mouse liver is highly susceptible to tumor necrosis factor-alpha- and Fas-mediated apoptosis. Am J Pathol 161: 1273-1281.
14. Ishigami A, Kondo Y, Nanba R, Ohsawa T, Handa S, et al. (2004) SMP30 deficiency in mice causes an accumulation of neutral lipids and phospholipids in the liver and shortens the life span. Biochem Biophys Res Commun 315: 575-580. (Pubitemid 38229382)
15. Son TG, Zou Y, Jung KJ, Yu BP, Ishigami A, et al. (2006) SMP30 deficiency causes increased oxidative stress in brain. Mech Ageing Dev 127: 451-457.
16. Sato T, Seyama K, Sato Y, Mori H, Souma S, et al. (2006) Senescence marker protein-30 protects mice lungs from oxidative stress, aging, and smoking. Am J Respir Crit Care Med 174: 530-537. (Pubitemid 44330545)
17. Yumura W, Imasawa T, Suganuma S, Ishigami A, Handa S, et al. (2006) Accelerated tubular cell senescence in SMP30 knockout mice. Histol Histopathol 21: 1151-1156. (Pubitemid 44614496)
18. Hasegawa G, Yamasaki M, Kadono M, Tanaka M, Asano M, et al. (2010) Senescence marker protein-30/gluconolactonase deletion worsens glucose tolerance through impairment of acute insulin secretion. Endocrinology 151: 529-536.
19. Misaka T, Suzuki S, Miyata M, Kobayashi A, Saitoh S, et al. (2011) Senescence marker protein 30 inhibits angiotensin II-induced cardiac remodeling. Circulation 124: A8880.
20. Arimoto T, Takeishi Y, Takahashi H, Shishido T, Niizeki T, et al. (2006) Cardiac-specific overexpression of diacylglycerol kinase zeta prevents Gq protein- coupled receptor agonist-induced cardiac hypertrophy in transgenic mice. Circulation 113: 60-66. (Pubitemid 43958489)
21. Tsao CS, Leung PY, Young M (1987) Effect of dietary ascorbic acid intake on tissue vitamin C in mice. J Nutr 117: 291-297. (Pubitemid 17047075)
22. Du J, Liu J, Feng HZ, Hossain MM, Gobara N, et al. (2008) Impaired relaxation is the main manifestation in transgenic mice expressing a restrictive cardiomyopathy mutation, R193H, in cardiac TnI. Am J Physiol Heart Circ Physiol 294: H2604-2613.
23. Wu J, Bu L, Gong H, Jiang G, Li L, et al. (2010) Effects of heart rate and anesthetic timing on high-resolution echocardiographic assessment under isoflurane anesthesia in mice. J Ultrasound Med 29: 1771-1778.
24. Machii H, Saitoh S, Kaneshiro T, Takeishi Y (2010) Aging impairs myocardium-induced dilation in coronary arterioles: role of hydrogen peroxide and angiotensin. Mech Ageing Dev 131: 710-717.
25. Takimoto E, Champion HC, Li M, Ren S, Rodriguez ER, et al. (2005) Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load. J Clin Invest 115: 1221-1231. (Pubitemid 40629040)
26. Martinet W, Knaapen MW, De Meyer GR, Herman AG, Kockx MM (2002) Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 106: 927-932. (Pubitemid 34925325)
27. Ichiseki T, Kaneuji A, Katsuda S, Ueda Y, Sugimori T, et al. (2005) DNA oxidation injury in bone early after steroid administration is involved in the pathogenesis of steroid-induced osteonecrosis. Rheumatology (Oxford). 44: 456-460. (Pubitemid 41511133)
28. Nozaki N, Shishido T, Takeishi Y, Kubota I (2004) Modulation of doxorubicin-induced cardiac dysfunction in toll-like receptor-2-knockout mice. Circulation 110: 2869-2874. (Pubitemid 39473611)
29. Dimri GP, Lee X, Basile G, Acosta M, Scott G, et al. (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 92: 9363-9367.
30. Mollnau H, Wendt M, Szocs K, Lassegue B, Schulz E, et al. (2002) Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 90: E58-65.
31. Singal PK, Iliskovic N (1998) Doxorubicin-induced cardiomyopathy. N Engl J Med 339: 900-905. (Pubitemid 28446849)
32. Iliskovic N, Li T, Khaper N, Palace V, Singal PK (1998) Modulation of adriamycin-induced changes in serum free fatty acids, albumin and cardiac oxidative stress. Mol Cell Biochem 188: 161-166. (Pubitemid 28493328)
33. Yeh ET, Tong AT, Lenihan DJ, Yusuf SW, Swafford J, et al. (2004) Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation 109: 3122-3131.
34. Ewer MS, Lippman SM (2005) Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity. J Clin Oncol 23: 2900-2902. (Pubitemid 46224107)
35. Bernhard D, Laufer G (2008) The aging cardiomyocyte: a mini-review. Gerontology 54: 24-31. (Pubitemid 351650654)
36. Jung KJ, Ishigami A, Maruyama N, Takahashi R, Goto S, et al. (2004) Modulation of gene expression of SMP-30 by LPS and calorie restriction during aging process. Exp Gerontol 39: 1169-1177. (Pubitemid 39024366)